University of Glasgow
Glasgow, G12 8QQ, United Kingdom
NCT Number: NCT00268541
Offspring of patients with type 2 diabetes have increased risk of developing diabetes and are typically more insulin resistant than their peers with no diabetes family history. We have recently demonstrated that, in contrast to their sedentary counterparts, physically active offspring are not insulin resistant. In the proposed controlled clinical study, we will examine the effects of a moderate exercise programme on insulin resistance, and other metabolic risk factors, in sedentary offspring and matched control subjects. We hypothesise that offspring will exhibit an augmented response to exercise, thereby normalising their predisposition to an adverse metabolic profile. We will also investigate expression of adipokines and other genes in adipose tissue to determine whether these contribute to the increased insulin resistance observed in offspring and whether they are influenced by exercise. The results will help to determine the efficacy of exercise in normalising metabolism in offspring and will help elucidate the mechanisms involved.
Looking for future studies?
Notify Me20 year–45 year
Female
Interventional
Not applicable
Glasgow, G12 8QQ, United Kingdom
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
NHS Greater Glasgow and Clyde
Other
Physical Activity, Insulin Resistance and Adipose Tissue Gene Expression in the Offspring of Patients With Type 2 Diabetes
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02432924
Behavior, Cardiovascular Diseases
Bath, United Kingdom
View Trial DetailsNCT01047735
Arterial Occlusive Diseases, Arteriosclerosis
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT05073692
Cardiovascular Diseases, Diabetes Mellitus
Pasadena, California, United States
View Trial DetailsNCT03769883
Behavior, Diabetes Mellitus
Copenhagen, Denmark
View Trial Details